Search for Clinical Trial Results
Desmoplastic Small Round Cell Tumor - 18 Studies Found
Status | Study |
Completed |
Study Name: Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors Condition: Refractory Desmoplastic Small Round Cell Tumors Date: 2007-01-02 Interventions: Drug: Imatinib mesilate Other Name: STI571 |
Active, not recruiting |
Study Name: Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor Condition:
Date: 2010-08-25 Interventions: Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator |
Recruiting |
Study Name: Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Condition: Peritoneal Cancer Date: 2010-04-06 Interventions: Biological: 131 I-8H9 Patients will be administered therapeutic dose of IP 131I-8H9 per the dose escalat |
Active, not recruiting |
Study Name: Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors Condition:
|
Completed |
Study Name: Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 Condition: Sarcoma Date: 2011-09-07 Interventions:
|
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor Condition: Sarcoma Date: 2003-06-05 Interventions: Drug: imatinib mesylate |
Completed |
Study Name: QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors Condition:
Interventions: Drug: AMG 479 AMG 479 is a fully human monoclonal antibody (IgG1) against the insulin-like growth factor |
Completed |
Study Name: Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor Condition: Sarcoma Date: 2003-03-06 Interventions: Drug: exatecan mesylate |
Completed |
Study Name: Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Condition:
|
Suspended |
Study Name: Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma Condition:
|